ÐÓ°ÉÊÓÆµ

Skip to main content
Front of HEC

School of Medicine

From driving cutting-edge research to bringing medical innovations to market, landing competitive awards and more, the faculty, staff and students at ÐÓ°ÉÊÓÆµ know how to make headlines.

Recent News

First and Only Study on Harmful Effects of Infants Prenatally Exposed to Ecstasy
CLEVELAND - A study led by ÐÓ°ÉÊÓÆµ School of Medicine, in collaboration with the University of East London UK, and Swansea University UK, is the first to show the effects of the drug ecstasy on fetal and infant development. Ecstasy is a stimulant and hallucinogen, and is…
Circadian Rhythms Linked to Sudden Cardiac Death, Study Finds
CLEVELAND - A fundamental discovery reported in the March 1st issue of the journal Nature, uncovers the first molecular evidence linking the body’s natural circadian rhythms to sudden cardiac death (SCD). Ventricular arrhythmias, or abnormal heart rhythms, are the most common cause of sudden…
Drug Quickly Reverses Alzheimer’s Symptoms in Mice
CLEVELAND - Neuroscientists at ÐÓ°ÉÊÓÆµ School of Medicine have made a dramatic breakthrough in their efforts to find a cure for Alzheimer’s disease. The researchers’ findings, published in the journal Science, show that use of a drug in mice appears to quickly reverse the…
Emergency Departments’ Quality Evaluation Requires Hospital-wide Effort
CLEVELAND - Time can be important in an emergency department especially in a busy Level 1 Trauma Center like MetroHealth Medical Center in Cleveland, when getting patients appropriate care is essential. However, when the quality of an emergency department is judged by a patient’s length of stay,…
$6.75M Awarded to ÐÓ°ÉÊÓÆµ to Study IBD
CLEVELAND - Investigators at ÐÓ°ÉÊÓÆµ School of Medicine received a $6.75 million Program Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to study the role of innate immunity in inflammatory bowel disease (IBD). For years,…
Cell Surface Mutation Protects Against Common Type of Malaria
CLEVELAND - A mutation on the surface of human red blood cells provides protection against malaria caused by the parasite Plasmodium vivax, research led by ÐÓ°ÉÊÓÆµ School of Medicine shows. The minute change, at a single position of red blood cell surface protein called the…
Early sign of Alzheimer’s reversed in lab
One of the earliest known impairments caused by Alzheimer’s disease—loss of sense of smell—can be restored by removing a plaque-forming protein in a mouse model of the disease, a study led by a ÐÓ°ÉÊÓÆµ School of Medicine researcher finds. The study confirms that the…
$3.8M Grant Investigates Link Between Sleep Apnea and Atrial Fibrillation
CLEVELAND - ÐÓ°ÉÊÓÆµ School of Medicine has received a $3.8 million grant from the National Heart, Lung, and Blood Institute (NHLBI) to study sleep apnea as a possible cause of atrial fibrillation (AF), the most commonly diagnosed type of arrhythmia, or irregular heart…
Lentingen and UH Case Medical Center Initiate Phase I Trial Using Gene Therapy and Bone Marrow Stem Cells in the Treatment of Brain Cancer
CLEVELAND - University Hospitals (UH) Case Medical Center, ÐÓ°ÉÊÓÆµ School of Medicine and Lentigen Corporation announced today the initiation of a novel Phase I clinical trial of LG631 gene therapy for the protection of hematopoietic stem cells (HSCs) from the dose limiting…
Society for Integrative Oncology Releases Findings Presented at Annual Meeting
CLEVELAND - Today the Society for Integrative Oncology highlighted top research findings presented at the Eighth International Conference this week in Cleveland, Ohio, which is co-sponsored by ÐÓ°ÉÊÓÆµ School of Medicine. More than 80 abstracts will be presented at the annual…